Page last updated: 2024-10-31

mirtazapine and Psychoses, Drug

mirtazapine has been researched along with Psychoses, Drug in 3 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Research Excerpts

ExcerptRelevanceReference
"Mirtazapine has a specific pharmacodynamics, blocking not only post-synaptic serotonergic receptors but also α2-presynaptic adrenergic receptors."1.51[Mirtazapine-Induced Mania: A Case Report]. ( Abreu, T; Barranha, R; Freitas, C; Von Doellinger, O, 2019)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freitas, C1
Barranha, R1
Abreu, T1
Von Doellinger, O1
Hamadjida, A1
Nuara, SG1
Veyres, N1
Frouni, I1
Kwan, C1
Sid-Otmane, L1
Harraka, MJ1
Gourdon, JC1
Huot, P1
Normann, C1
Hesslinger, B1
Frauenknecht, S1
Berger, M1
Walden, J1

Other Studies

3 other studies available for mirtazapine and Psychoses, Drug

ArticleYear
[Mirtazapine-Induced Mania: A Case Report].
    Acta medica portuguesa, 2019, Oct-01, Volume: 32, Issue:10

    Topics: Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Middle Aged; Mirtazapin

2019
The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset.
    Psychopharmacology, 2017, Volume: 234, Issue:6

    Topics: Animals; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Behavior, Animal; Callithrix; Dyski

2017
Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
    Pharmacopsychiatry, 1997, Volume: 30, Issue:6

    Topics: Adult; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Depressive Disorder; Drug Interaction

1997